COMING SOON: A Conversation With The FDA/DDMAC Regarding Guidance for Drug Promotion Using Internet & Social Media
In a new, soon-to-be published interview, the FDA re-emphasizes its need for comments and data from the public, and also explains why it's not too late for companies to start gathering their data now, despite the upcoming Feb 28, 2010 deadline.
On January 28, 2010 Fabio Gratton, Chief Innovation Officer of Ignite Health and founder of FDASM.COM, sat down with Dr. Jean-Ah Kang, Special Assistant to DDMAC Director Thomas Abrams, for a 2-hour interview at FDA's Silver Spring (MD) offices to discuss the recent Part 15 public hearings on promotion of FDA-regulated medical products using the Internet and Social Media Tools -- some of the topics covered include the guidance process, the comments period, the public criticism, and What the Industry Can Do Now.
